Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 589 with Last Name = 'isoshima' and Initial = 'h'
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137945(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137956(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137945(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137949(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-[1,4]di...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137940(Biphenyl-2-carboxylic acid [2-[4-(4-dimethylamino-...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137940(Biphenyl-2-carboxylic acid [2-[4-(4-dimethylamino-...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272201(US10065950, Example 42)
Affinity DataIC50:  3.40nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137953(Biphenyl-2-carboxylic acid [2-[4-(4-diethylamino-p...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137946(Biphenyl-2-carboxylic acid [2-[2-(4-dimethylamino-...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137953(Biphenyl-2-carboxylic acid [2-[4-(4-diethylamino-p...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272314(US10065950, Example 156)
Affinity DataIC50:  4.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272202(US10065950, Example 43)
Affinity DataIC50:  4.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272497(US10065950, Example 359)
Affinity DataIC50:  4.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272241(US10065950, Example 82)
Affinity DataIC50:  4.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137945(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137951(Biphenyl-2-carboxylic acid [2-{4-[(2-dimethylamino...)
Affinity DataIC50:  5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272208(US10065950, Example 49)
Affinity DataIC50:  5.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272373(US10065950, Example 217)
Affinity DataIC50:  5.30nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272309(US10065950, Example 151)
Affinity DataIC50:  5.40nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272316(US10065950, Example 158)
Affinity DataIC50:  5.40nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272303(US10065950, Example 145 | US10065950, Example 146)
Affinity DataIC50:  5.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272165(US10065950, Example 6)
Affinity DataIC50:  5.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272210(US10065950, Example 51)
Affinity DataIC50:  5.70nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272233(US10065950, Example 74)
Affinity DataIC50:  5.70nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272356(US10065950, Example 198 | US10065950, Example 206)
Affinity DataIC50:  5.70nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272475(US10065950, Example 319)
Affinity DataIC50:  5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272326(US10065950, Example 168)
Affinity DataIC50:  5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272311(US10065950, Example 153)
Affinity DataIC50:  5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272459(US10065950, Example 303)
Affinity DataIC50:  5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272298(US10065950, Example 140)
Affinity DataIC50:  5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272187(US10065950, Example 152 | US10065950, Example 28)
Affinity DataIC50:  5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272303(US10065950, Example 145 | US10065950, Example 146)
Affinity DataIC50:  5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272307(US10065950, Example 149)
Affinity DataIC50:  5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272356(US10065950, Example 198 | US10065950, Example 206)
Affinity DataIC50:  5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272479(US10065950, Example 327)
Affinity DataIC50:  5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272353(US10065950, Example 195)
Affinity DataIC50:  5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137940(Biphenyl-2-carboxylic acid [2-[4-(4-dimethylamino-...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137953(Biphenyl-2-carboxylic acid [2-[4-(4-diethylamino-p...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137956(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272342(US10065950, Example 184)
Affinity DataIC50:  6nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272257(US10065950, Example 99)
Affinity DataIC50:  6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272223(US10065950, Example 64)
Affinity DataIC50:  6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272481(US10065950, Example 329)
Affinity DataIC50:  6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272318(US10065950, Example 160)
Affinity DataIC50:  6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272308(US10065950, Example 150)
Affinity DataIC50:  6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco

US Patent
LigandPNGBDBM272192(US10065950, Example 33)
Affinity DataIC50:  6.20nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 589 total ) | Next | Last >>
Jump to: